These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 3822251)

  • 1. A disorder of cortical GABAergic innervation in Alzheimer's disease.
    Hardy J; Cowburn R; Barton A; Reynolds G; Dodd P; Wester P; O'Carroll AM; Lofdahl E; Winblad B
    Neurosci Lett; 1987 Jan; 73(2):192-6. PubMed ID: 3822251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Region-specific loss of glutamate innervation in Alzheimer's disease.
    Hardy J; Cowburn R; Barton A; Reynolds G; Lofdahl E; O'Carroll AM; Wester P; Winblad B
    Neurosci Lett; 1987 Jan; 73(1):77-80. PubMed ID: 2882446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alzheimer's disease: a multisystem disorder.
    Price DL; Struble RG; Whitehouse PJ; Kitt CA; Cork LC; Walker LC; Casanova MF
    Res Publ Assoc Res Nerv Ment Dis; 1986; 64():209-14. PubMed ID: 3523660
    [No Abstract]   [Full Text] [Related]  

  • 4. Alterations of signal transduction in the lesioned entorhinal-hippocampal system: a mini-review on Alzheimer's disease-related changes and experimental data.
    Ohm TG
    Hippocampus; 1993; 3 Spec No():131-8. PubMed ID: 8287091
    [No Abstract]   [Full Text] [Related]  

  • 5. Evidence for high affinity choline transport in synaptosomes prepared from hippocampus and neocortex of patients with Alzheimer's disease.
    Rylett RJ; Ball MJ; Colhoun EH
    Brain Res; 1983 Dec; 289(1-2):169-75. PubMed ID: 6661641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hippocampal-sparing Alzheimer's disease presenting as corticobasal syndrome.
    Malkani RG; Dickson DW; Simuni T
    Parkinsonism Relat Disord; 2012 Jun; 18(5):683-5. PubMed ID: 22172552
    [No Abstract]   [Full Text] [Related]  

  • 7. Cortical amino acidergic pathways in Alzheimer's disease.
    Young AB
    J Neural Transm Suppl; 1987; 24():147-52. PubMed ID: 2824688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A post-mortem study of the cholinergic and GABA systems in senile dementia.
    Rossor MN; Garrett NJ; Johnson AL; Mountjoy CQ; Roth M; Iversen LL
    Brain; 1982 Jun; 105(Pt 2):313-30. PubMed ID: 7082992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Magnetic stimulation in Alzheimer's disease.
    de Carvalho M; de Mendonça A; Miranda PC; Garcia C; Luís ML
    J Neurol; 1997 May; 244(5):304-7. PubMed ID: 9178155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gamma-aminobutyric acid concentration in brain tissue at two stages of Alzheimer's disease.
    Lowe SL; Francis PT; Procter AW; Palmer AM; Davison AN; Bowen DM
    Brain; 1988 Aug; 111 ( Pt 4)():785-99. PubMed ID: 3401683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective cholinergic denervation, independent from oxidative stress, in a mouse model of Alzheimer's disease.
    Aucoin JS; Jiang P; Aznavour N; Tong XK; Buttini M; Descarries L; Hamel E
    Neuroscience; 2005; 132(1):73-86. PubMed ID: 15780468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gender, GABAergic dysfunction and AD.
    Alia A; Roßner S
    Aging (Albany NY); 2018 Nov; 10(12):3636-3637. PubMed ID: 30476903
    [No Abstract]   [Full Text] [Related]  

  • 13. Hypothalamic pathology in Alzheimer's disease.
    Saper CB; German DC
    Neurosci Lett; 1987 Mar; 74(3):364-70. PubMed ID: 2436113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spatially distinct atrophy is linked to β-amyloid and tau in preclinical Alzheimer disease.
    Wang L; Benzinger TL; Hassenstab J; Blazey T; Owen C; Liu J; Fagan AM; Morris JC; Ances BM
    Neurology; 2015 Mar; 84(12):1254-60. PubMed ID: 25716355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for a GABAergic interface between cortical afferents and brainstem projection neurons in the rat central extended amygdala.
    Sun N; Yi H; Cassell MD
    J Comp Neurol; 1994 Feb; 340(1):43-64. PubMed ID: 7513719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glutamate and gamma-aminobutyric acid content and release of synaptosomes from temporal lobe epilepsy patients.
    Hoogland G; Hens JJ; De Wit M; van Veelen CW; van Huffelen AC; Gispen WH; de Graan PN
    J Neurosci Res; 2000 Jun; 60(5):686-95. PubMed ID: 10820440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Uptake of gamma-aminobutyric acid and L-glutamic acid by synaptosomes from postmortem human cerebral cortex: multiple sites, sodium dependence and effect of tissue preparation.
    Dodd PR; Watson WE; Morrison MM; Johnston GA; Bird ED; Cowburn RF; Hardy JA
    Brain Res; 1989 Jun; 490(2):320-31. PubMed ID: 2569904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurochemical characteristics of early and late onset types of Alzheimer's disease.
    Rossor MN; Iversen LL; Reynolds GP; Mountjoy CQ; Roth M
    Br Med J (Clin Res Ed); 1984 Mar; 288(6422):961-4. PubMed ID: 6142750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alzheimer's disease: a disorder of cortical cholinergic innervation.
    Coyle JT; Price DL; DeLong MR
    Science; 1983 Mar; 219(4589):1184-90. PubMed ID: 6338589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clonidine enhances the release of endogenous gamma-aminobutyric acid through alpha-2 and alpha-1 presynaptic adrenoceptors differentially located in rat cerebral cortex subregions.
    Pittaluga A; Raiteri M
    J Pharmacol Exp Ther; 1988 May; 245(2):682-6. PubMed ID: 2835479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.